The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy

The prognosis for people with the high-grade brain tumor glioblastoma is very poor, due largely to low cell death in response to genotoxic therapy. The transcription factor BCL6, a protein that normally suppresses the DNA damage response during immune cell maturation, and a known driver of B-cell ly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Fabre, Marie-Sophie, Stanton, Nicole M., Slatter, Tania L., Lee, Samuel, Senanayake, Dinindu, Gordon, Rosemary M. A., Castro, M. Leticia, Rowe, Matthew R., Taha, Ahmad, Royds, Janice A., Hung, Noelyn, Melnick, Ari M., McConnell, Melanie J.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7176076/
https://ncbi.nlm.nih.gov/pubmed/32320427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0231470
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados